Vasamed(OTC) VSMD

Vasamed, Inc. specializes in developing and distributing innovative products and services focused on circulatory health management. The company offers advanced solutions for assessing and managing circulatory health, catering to both clinicians and patients.

Products and Services

• SensiLase PAD-IQ for measuring skin perfusion pressure
• Wound Imaging & SmartDraw systems for precise wound measurement
• PAD-IQ Studycast for secure transmission of diagnostic results

Growth Outlook

• Continued demand for circulatory health solutions drives market potential
• Expansion of product offerings enhances competitive positioning
• Strategic partnerships may lead to increased market penetration

Financial Highlights

• Recent quarterly revenue of 513,127 shows growth potential
• Trailing twelve months (TTM) operating income margin at 3.42%
• Current ratio of 0.98 indicates liquidity management

Vasamed, Inc. has been operational since 1988 and is headquartered in Eden Prairie, Minnesota. The company focuses on providing essential tools for healthcare professionals, particularly in the assessment of circulatory health. The SensiLase PAD-IQ device is a key offering, allowing for accurate measurements that are critical in vascular health assessments. The company also emphasizes the importance of timely diagnostic results through its PAD-IQ Studycast platform, which facilitates rapid communication between clinicians and specialists. The growth outlook for Vasamed appears promising, driven by an increasing demand for circulatory health solutions and the potential for strategic partnerships. Recent financial data indicates a revenue increase, suggesting a positive trajectory for the company. The operating income margin reflects effective cost management, while the current ratio indicates a stable liquidity position. Overall, Vasamed, Inc. presents an intriguing opportunity within the healthcare sector, particularly for those interested in innovative medical instruments and supplies.